Literature DB >> 24779349

High resolution metabolite imaging in the hippocampus following neonatal exposure to the environmental toxin BMAA using ToF-SIMS.

Jörg Hanrieder1, Lorenz Gerber, Åsa Persson Sandelius, Eva B Brittebo, Andrew G Ewing, Oskar Karlsson.   

Abstract

The environmental neurotoxin β-N-methylamino-L-alanine (BMAA) is suggested to be linked with neurodegenerative disease. In a rat model, neonatal exposure to BMAA induced selective uptake in the hippocampus and caused cell loss, mineralization and astrogliosis as well as learning and memory impairments in adulthood. Moreover, neonatal exposure resulted in increased protein ubiquitination in the cornus ammonis 1 (CA1) region of the adult hippocampus indicating that BMAA may induce protein aggregation. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) based imaging is a powerful technology for spatial profiling of small molecular weight compounds in biological tissues with high chemical specificity and high spatial resolution. The aim of this study was to characterize neurochemical changes in the hippocampus of six month-old rats treated neonatally (postnatal days 9-10) with BMAA. Multivariate data analysis of whole section ToF-SIMS scans was performed to delineate anatomical regions of interest based on their chemical distribution pattern. Further analysis of spectral data obtained from the outlined anatomical regions, including CA1 and dentate gyrus (DG) revealed BMAA-induced long-term changes. Increased levels of phospholipids and protein fragments in the histopathologically altered CA1 region as well as phosphate depletion in the DG were observed. Moreover, high resolution SIMS imaging revealed a specific localization of phosphatidylcholine lipids, protein signals and potassium in the histopathologically altered CA1. These findings demonstrate that ToF-SIMS based imaging is a powerful approach for probing biochemical changes in situ and might serve as promising technique for investigating neurotoxin-induced brain pathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24779349      PMCID: PMC4102959          DOI: 10.1021/cn500039b

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  29 in total

1.  High extracellular K(+) evokes changes in voltage-dependent K(+) and Na (+) currents and volume regulation in astrocytes.

Authors:  Helena Neprasova; Miroslava Anderova; David Petrik; Lydia Vargova; Sarka Kubinova; Alexandr Chvatal; Eva Sykova
Journal:  Pflugers Arch       Date:  2006-10-10       Impact factor: 3.657

Review 2.  Imaging mass spectrometry in neuroscience.

Authors:  Jörg Hanrieder; Nhu T N Phan; Michael E Kurczy; Andrew G Ewing
Journal:  ACS Chem Neurosci       Date:  2013-04-30       Impact factor: 4.418

3.  Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs.

Authors:  Larry E Brand; John Pablo; Angela Compton; Neil Hammerschlag; Deborah C Mash
Journal:  Harmful Algae       Date:  2010-09-01       Impact factor: 4.273

4.  Early hippocampal cell death, and late learning and memory deficits in rats exposed to the environmental toxin BMAA (β-N-methylamino-L-alanine) during the neonatal period.

Authors:  Oskar Karlsson; Erika Roman; Anna-Lena Berg; Eva B Brittebo
Journal:  Behav Brain Res       Date:  2011-02-12       Impact factor: 3.332

5.  Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (beta-N-methylamino-L-alanine) following neonatal administration to rodents.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist; Eva B Brittebo; Erika Roman
Journal:  Toxicol Sci       Date:  2009-03-25       Impact factor: 4.849

6.  Protein association of the neurotoxin and non-protein amino acid BMAA (β-N-methylamino-L-alanine) in the liver and brain following neonatal administration in rats.

Authors:  Oskar Karlsson; Liying Jiang; Marie Andersson; Leopold L Ilag; Eva B Brittebo
Journal:  Toxicol Lett       Date:  2014-01-26       Impact factor: 4.372

7.  Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.

Authors:  Oskar Karlsson; Cecilia Berg; Eva B Brittebo; Nils Gunnar Lindquist
Journal:  Pigment Cell Melanoma Res       Date:  2009-02       Impact factor: 4.693

8.  Diatoms: a novel source for the neurotoxin BMAA in aquatic environments.

Authors:  Liying Jiang; Johan Eriksson; Sandra Lage; Sara Jonasson; Shiva Shams; Martin Mehine; Leopold L Ilag; Ulla Rasmussen
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

9.  Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA).

Authors:  Oskar Karlsson; Jonas Bergquist; Malin Andersson
Journal:  Mol Cell Proteomics       Date:  2013-10-14       Impact factor: 5.911

10.  Intracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAA.

Authors:  Oskar Karlsson; Anna-Lena Berg; Jörg Hanrieder; Gunnel Arnerup; Anna-Karin Lindström; Eva B Brittebo
Journal:  Arch Toxicol       Date:  2014-05-06       Impact factor: 5.153

View more
  9 in total

1.  Brain region mapping using global metabolomics.

Authors:  Julijana Ivanisevic; Adrian A Epstein; Michael E Kurczy; Paul H Benton; Winnie Uritboonthai; Howard S Fox; Michael D Boska; Howard E Gendelman; Gary Siuzdak
Journal:  Chem Biol       Date:  2014-11-20

Review 2.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

3.  Simultaneous Multiplexed Imaging of Biomolecules in Transgenic Mouse Brain Tissues Using Mass Spectrometry Imaging: A Multi-omic Approach.

Authors:  Minh-Uyen Thi Le; Hyun Kyong Shon; Hong-Phuong Nguyen; Chul-Ho Lee; Kyoung-Shim Kim; Hee-Kyung Na; Tae Geol Lee
Journal:  Anal Chem       Date:  2022-06-13       Impact factor: 8.008

4.  MALDI imaging delineates hippocampal glycosphingolipid changes associated with neurotoxin induced proteopathy following neonatal BMAA exposure.

Authors:  Oskar Karlsson; Wojciech Michno; Yusuf Ransome; Jörg Hanrieder
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2016-12-09       Impact factor: 3.036

Review 5.  Single Cell Neurometabolomics.

Authors:  Meng Qi; Marina C Philip; Ning Yang; Jonathan V Sweedler
Journal:  ACS Chem Neurosci       Date:  2017-10-19       Impact factor: 4.418

6.  Food-induced changes of lipids in rat neuronal tissue visualized by ToF-SIMS imaging.

Authors:  Masoumeh Dowlatshahi Pour; Eva Jennische; Stefan Lange; Andrew G Ewing; Per Malmberg
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

7.  Precise Anatomic Localization of Accumulated Lipids in Mfp2 Deficient Murine Brains Through Automated Registration of SIMS Images to the Allen Brain Atlas.

Authors:  Karolina Škrášková; Artem Khmelinskii; Walid M Abdelmoula; Stephanie De Munter; Myriam Baes; Liam McDonnell; Jouke Dijkstra; Ron M A Heeren
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-28       Impact factor: 3.109

8.  Environmental neurotoxin interaction with proteins: Dose-dependent increase of free and protein-associated BMAA (β-N-methylamino-L-alanine) in neonatal rat brain.

Authors:  Oskar Karlsson; Liying Jiang; Lisa Ersson; Tim Malmström; Leopold L Ilag; Eva B Brittebo
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

Review 9.  Imaging mass spectrometry in drug development and toxicology.

Authors:  Oskar Karlsson; Jörg Hanrieder
Journal:  Arch Toxicol       Date:  2016-12-08       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.